Radioactive Iodine Ablation Therapy Market

Future Market Insights

Key Insight

The radioactive iodine ablation therapy market is projected to grow from USD 535.2 million in 2025 to USD 871.8 million by 2035, at a CAGR of 5.0%. Papillary Thyroid Cancer will dominate with a 54.6% market share, while gamma radiation will lead the technology segment with a 61.2% share.

October 04, 2025

Anurag Sharma

275 Pages

Cite this Report

Radioactive Iodine Ablation Therapy Market

https://www.futuremarketinsights.com/reports/radioactive-iodine-ablation-therapy-market

License

Buy Now

Summary ToC Companies

Key Players

AngioDynamics
Boston Scientific
Galil Medical Inc
Healthtronics
Medtronic plc
Misonix Inc
Neuwave Medical Inc
SonaCare Medical

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Radioactive Iodine Ablation Therapy Market

Key Players

Similar Industry Reports